Siemens Healthineers Showcases Cutting-Edge Laboratory Diagnostic Portfolios at EGY Health 2021

Siemens Healthineers, a leader in healthcare imaging and diagnostic technology, is showcasing a variety of its cutting-edge laboratory diagnostic portfolios at the EGY Health International Congress and Exhibition taking place on September 7-9, 2021, in the Egyptian International Exhibition Center (EIEC).

“Industry events, such as EGY Health, that convene an impressive depth and breadth of stakeholders from across the medical field are crucial to the mission of Siemens Healthineers,” said Michael Schmermer, Managing Director Siemens Healthineers - Egypt, Djibouti, Eretria, Sudan, and Libya.  “We know that strong partnerships improve access to healthcare. We look forward to strengthening our existing partnerships and creating new business relationships as we continue to drive innovation to help humans live healthier and longer.”

Siemens Healthineers is not only featuring innovative products from several portfolios at the event but is also presenting during the Congress. On Sept. 9th, Eng. Mohamed Gharib, Automation & Diagnostics IT Business Manager, Middle East and Africa at Siemens Healthineers will be speaking on the topic of lab digitalization and workflow excellence.

Throughout the three-day event, Siemens Healthineers will be showcasing some of it laboratory diagnostic solutions such as Covid-19 portfolio: FTD SARS COV 2, Clinitest Covid-19 AG rapid test, and SARS COV 2 antibody (Total & IgG); the Atellica portfolio: Atellica Solution, Atellica Neph 630, and Atellica Hematology; the Hemostasis portfolio; the POC portfolio, the Atellica VTLI, Atellica DCA, and the Atellica Urine. 

Siemens Healthineers is a leading medical technology company with over 120 years of experience, 18,500 patents globally, and over 50,000 employees in more than 70 countries. An estimated five million patients worldwide everyday benefit from the company’s innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services.